Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 248, Issue 8, 2010, Pages 1203-

  Shroff, Daraius ^a   Bhargava, Arun ^b   Sharma, Bhavana ^a   Gupta, Charu ^a   Shroff, Cyrus ^a  

^a Shroff Eye Centre   (India)

^b Sree Swaminarayan Gurukul Eye Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE;

COMPARATIVE STUDY; DRUG RESPONSE; HUMAN; LETTER; MONOTHERAPY; PRIORITY JOURNAL; RETINA VEIN OCCLUSION; RETREATMENT; TACHYPHYLAXIS; TREATMENT OUTCOME;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HUMANS; INJECTIONS; PROGNOSIS; RETINAL VEIN OCCLUSION; RETREATMENT; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 77955554839     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-010-1353-6     Document Type: Letter

References (3)

1. Ehrlich R, Ciulla TA, Moss AM, Harris A (2009) Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion: 6 months of follow-up. Graefes Arch Clin Exp Ophthalmol. Nov 8. [Epub ahead of print]
2. F Prager S Michels K Kriechbaum M Georgopoulos M Funk W Geitzenauer K Polak U Schmidt-Erfurth 2009 Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial Br J Ophthalmol 93 452 456 10.1136/bjo.2008.141085 1:STN:280:DC%2BD1M3jt1ejug%3D%3D 19074916
3. S Schaal HJ Kaplan TH Tezel 2008 Is there tachyphylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in age-related macular degeneration? Ophthalmology 115 2199 2205 10.1016/j.ophtha.2008.07.007 18930553